HUG - Geneva University Hospitals

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

April, 2025

HUG – Geneva University Hospitals

Jul 24, 2024, 01:01 | Blog

Timothée Olivier: Interim data of early phase results from novel RAS inhibitor in pancreatic cancer

Timothée Olivier, Medical Oncologist at HUG – Geneva University Hospitals, shared his previous post on X,…

May 28, 2024, 14:05 | Blog

Timothée Olivier: How applying FDA censoring rules can double the PFS benefit by Vinay Prasad

Timothée Olivier, Medical Oncologist at HUG – Geneva University Hospitals, shared a post on X:…

May 27, 2024, 06:35 | Blog

Timothée Olivier: An academic study addressing a practical clinical question!

Timothée Olivier, Medical Oncologist at HUG – Geneva University Hospitals, shared a post on X:…

Apr 5, 2024, 18:16 | Insight

Timothée Olivier: NATALEE trial, adjuvant ribociclib 21 days/28 for… 3 years! Cost alert!!

Timothée Olivier, Medical Oncologist at HUG - Geneva University Hospitals, shared a post by the…

All: 4 Posts: 1 - 100

'

FDA Approves Penpulimab for Recurrent or Metastatic Non-Keratinizing Nasopharyngeal Carcinoma

'

Senate President Passes Away After Brave Battle with Cancer: Dominick J. Ruggerio

'

Where to Study to Become ASCO President: 2025 Institutional Rankings

'

Yelak Biru: UK grants first approval for Blenrep in multiple myeloma

'

Eric Abidal and Liver Cancer: How He Returned to Football After Overcoming Illness

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023